Loading…
| # | Company | Offered Item | Amount | Rank | Status |
|---|---|---|---|---|---|
| 1 | L1₹8.7 LQualified Make: CIPLA
Model: TRULICITY 1.5MG/0.5ML
Title: DULAGLUTIDE 1.5MG/0.5ML INJECTION 46 1965 VAKKATTU ROAD CHAKKARAPARAMBU THAMMANAM P O ERNAKULAM KERALA 682032 | ERNAKULAM | KERALA | 682032 | Make: CIPLA
Model: TRULICITY 1.5MG/0.5ML
Title: DULAGLUTIDE 1.5MG/0.5ML INJECTION | L1 | Qualified |
Tender Value
Refer Docs
EMD Value
Exempted
Closing Date
24 May 2025, 9:00 amClosed
DULAGLUTIDE 1.5MG/0.5ML INJECTION
7784953
GEM/2025/B/6180815
Two Packet Bid
DULAGLUTIDE 1.5MG/0.5ML INJECTION
GeM Contract
1 days
Kumar Wagji759145PURCHASE DEPARTMENT, NALCO SMELTER PLANT, NALCO NAGAR Quantit y Delivery to start after Delivery to be completed by __________
Total value wise evaluation
PRODUCT_CUSTOM
Awarded to Synergy Associates
₹8.7 L
| Product | Brand / Model | HSN | Quantity | Unit Price | Amount |
|---|---|---|---|---|---|
| DULAGLUTIDE 1.5MG/0.5ML INJECTION | CIPLA / TRULICITY 1.5MG/0.5ML | HSN not specified by seller | 400 pieces | 2,172.8 | 869,120 |
4 documents required · 4 mandatory
Exempted
5 Aug 2025
3 May 2025
24 May 2025
DULAGLUTIDE 1.5MG/0.5ML INJECTION | Brand:CIPLA | Model:TRULICITY 1.5MG/0.5ML | HSN:HSN not specified by seller | Qty:400 pieces | UnitPrice:2,172.8 | Amount:869,120
contract_GEMC-511687744859019.pdf
GEM_CONTRACT • 0.08 MB
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_7784953.pdf
GEM_BID
nit_tech_specification_medicine_2025-04-29-10-56-55_83aa002570dce19c1f0850ade6ea0383.pdf
SPECIFICATION
1745906620.pdf
OTHER
NB5_e9c9131e-48d2-4bdb-b16d1745983120729_sandipsahoo.doc
OTHER
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .